Tfg Advisers LLC Amgen Inc Transaction History

Tfg Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $182,307 - $231,643	796 New	796 $209,000
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $197,987 - $235,768	-915 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $11,732 - $13,047	50 Added 5.78%	915 $232,000
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $171,105 - $209,970	865 New	865 $204,000
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $157,455 - $208,828	-864 Closed	0 $0
Q4 2019 Mar 16, 2020	BUY	$189.21 - $243.2 $163,477 - $210,124	864 New	864 $208,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Tfg Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Tfg Advisers LLC with notifications on news.